Immune checkpoints play a critical role in preventing autoimmunity and maintaining self-tolerance, but they can also be exploited by cancer cells to evade the immune system. There are several different types of immune checkpoints, including CTLA-4, PD-1, and LAG-3. In recent years, drugs that target these checkpoints have been developed as a new class of cancer immunotherapy.
Immune checkpoint catalytic receptors
- B and T lymphocyte attenuator, herpes virus entry mediator
Starting at $1,334.90
- LIGHT, herpes virus entry mediator;lymphotoxin β receptor
Starting at $1,334.90